InMed Pharmaceuticals Inc. - Common Shares (NQ:INM)

1.330 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about InMed Pharmaceuticals Inc. - Common Shares

< Previous 1 2 3 4 5 6 7 8 9

...

15 16 Next >

TinyGemsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Appoints Interim Chief Financial Officer, Changes Auditor

December 13, 2022

Via Investor Brand Network

InMed Announces Appointment of Interim Chief Financial Officer and Change of Auditor

December 12, 2022

From InMed Pharmaceuticals Inc.

Via GlobeNewswire

InMed Pharmaceuticals Secures $6M Via Private Placement ↗

November 22, 2022

InMed Pharmaceuticals Inc. (NASDAQ: INM) closed its private placement with two healthcare-focused institutional investors for the issuance and sale of 1.8 million of its common shares

Via Benzinga

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Close on $6M Private Placement Funding

November 22, 2022

Via Investor Brand Network

Topics Intellectual Property

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Close on $6M Private Placement Funding

November 22, 2022

Via CannabisNewsWire

Topics Intellectual Property

InMed Pharmaceuticals Announces Closing of $6 Million Private Placement Priced at a Premium to Market

November 21, 2022

From InMed Pharmaceuticals Inc.

Via GlobeNewswire

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Anticipated $6M Private Placement Funding

November 18, 2022

Via Investor Brand Network

Topics Intellectual Property

Why InMed Pharmaceuticals Shares Tumbled 28%; Here Are 67 Biggest Movers From Friday ↗

November 21, 2022

Gainers AGBA Group Holding Limited (NASDAQ: AGBA) gained 50.7% to close at $6.78 on Friday.

Via Benzinga

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Anticipated $6M Private Placement Funding

November 18, 2022

Via CannabisNewsWire

Topics Intellectual Property

Why PaxMedica Shares Are Trading Higher By Over 53%? Here Are 47 Stocks Moving In Friday's Mid-Day Session ↗

November 18, 2022

Gainers PaxMedica, Inc. (NASDAQ: PXMD) gained 53.5% to $2.38 after the company announced an equity investment agreement for up to $20 million with Lincoln Park Capital.

Via Benzinga

InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market

November 18, 2022

From InMed Pharmaceuticals Inc.

Via GlobeNewswire

TinyGemsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Accounting VP, Controller

November 17, 2022

Via Investor Brand Network

InMed Provides Update on Management Changes

November 17, 2022

From InMed Pharmaceuticals Inc.

Via GlobeNewswire

InMed Pharmaceuticals (NASDAQ: INM) Says Research Grant to Test Cannabinoid Analogs as a Potential Treatment for Alzheimer’s, Parkinson’s and Huntington’s Disease

November 16, 2022

InMed Pharmaceuticals, Inc. (NASDAQ: INM) is a pharmaceutical research and development company that is focused on utilizing cannabinoids and related

Via Spotlight Growth

Why Foresight Autonomous Shares Jumped 33%; Here Are 83 Biggest Movers From Yesterday ↗

November 17, 2022

Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares surged 106.3% to close at $0.21 on Wednesday after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process.

Via Benzinga

S&P 500 Down 0.8%; Lowe's Earnings Top Expectations ↗

November 16, 2022

U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite dropping around 1.5% on Wednesday.

Via Benzinga

BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Gains Alliance Grant Funding, Launches New Program with UBC Professor

November 16, 2022

Via Investor Brand Network

Dow Edges Higher; Crude Oil Drops Sharply ↗

November 16, 2022

U.S. stocks traded mixed midway through trading, with the Dow Jones turning higher on Wednesday.

Via Benzinga

Why Target Shares Are Trading Lower By 14%? Here Are 56 Stocks Moving In Wednesday's Mid-Day Session ↗

November 16, 2022

Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares jumped 109% to $0.2115 after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process.

Via Benzinga

Nasdaq Drops Over 100 Points; US Retail Sales Rise 1.3% ↗

November 16, 2022

U.S. stocks traded mostly lower this morning, with the Nasdaq Composite dropping more than 100 points on Wednesday.

Via Benzinga

InMed Pharmaceuticals Advances Neurodegenerative Disease Program with Natural Sciences and Engineering Research Council of Canada ("NSERC") Alliance Grant Funding

November 16, 2022

From InMed Pharmaceuticals Inc.

Via GlobeNewswire

Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 67 Stocks Moving In Tuesday's Mid-Day Session ↗

November 15, 2022

Gainers SenesTech, Inc. (NASDAQ: SNES) shares surged 91.7% to $0.2751. SenesTech reported a 1-for-20 reverse stock split.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

November 15, 2022

We're starting off the day with a look at the biggest pre-market stock movers that traders will want to know about for Tuesday morning!

Via InvestorPlace

TinyGemsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Q1 2023 Financial Report, Corporate Update

November 14, 2022

Via Investor Brand Network

Tyson Foods, AECOM And 3 Stocks To Watch Heading Into Monday ↗

November 14, 2022

With US stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

InMed Pharmaceuticals Reports First Quarter Fiscal 2023 Financial Results and Provides Business Update

November 11, 2022

From InMed Pharmaceuticals Inc.

Via GlobeNewswire

BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Present at ‘Exploring the Neuroprotective Qualities of Rare Cannabinoids’ Webinar Event

November 10, 2022

Via Investor Brand Network

Registration Now Open For Tribe Public’s Webinar Event "Exploring the Neuroprotective Qualities of Rare Cannabinoids" Featuring InMed’s Management Team On November 17, 2022

November 10, 2022

Meet with InMed’s President and CEO Eric A. Adams and Eric Hsu, SVP of Preclinical Research and Development

From InMed Pharmaceuticals Inc.

Via GlobeNewswire

Stocks That Hit 52-Week Lows On Monday ↗

October 31, 2022

During Monday's session, 96 stocks hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

October 27, 2022

On Thursday, 111 stocks hit new 52-week lows.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.